Research Article
Serum Levels of Three Angiogenic Factors in Systemic Lupus Erythematosus and Their Clinical Significance
Table 1
Clinical data among groups (mean ± standard deviation).
| | Control group | All SLE group | Active SLE group | Inactive SLE group |
| Number of cases | 28 | 54 | 36 | 18 | Age | | | | | Gender (F/M) | 22/6 | 50/4 | 34/2 | 16/2 | SBP (mmHg) | | | | | DBP (mmHg) | | 80.69 ± 18.867a | 84.36 ± 19.97b | 73.33 ± 14.25d | Hb (g/L) | | 113.96 ± 20.84a | 108.22 ± 21.71b | 125.44 ± 13.19cd | Plt (109/L) | | 167.31 ± 83.35a | 165.36 ± 95.04 | 171.22 ± 55.11 | TC (mmol/L) | | 5.56 ± 2.41 | 5.78 ± 2.58 | 5.12 ± 12.03 | TG (mmol/L) | | 2.20 ± 1.43 | 2.42 ± 1.62b | 1.74 ± 0.79d | Alb (g/L) | | 33.42 ± 8.18a | 31.80 ± 7.88b | 36.68 ± 8.00cd | Cr-s (µmol/L) | | 86.66 ± 68.23 | 97.03 ± 81.57b | 65.92 ± 11.50d | UA (mmol/L) | | 314.24 ± 134.31 | 330.93 ± 155.32 | 280.85 ± 69.29c | FBG (mmol/L) | | 5.10 ± 0.89a | 5.17 ± 0.09b | 4.95 ± 0.91c |
|
|
Note: When compared with the control group, a, b, and c; When compared with the active SLE group, d.
|